Evidence map›Paper›PMID 34206061›Full record

ArticleJournal of clinical medicine2021

Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillance.

Aysel Ahadova, Pauline Luise Pfuderer, Maarit Ahtiainen, Alexej Ballhausen, Lena Bohaumilitzky, Svenja Kösegi, Nico Müller, Yee Lin Tang, Kosima Kosmalla, Johannes Witt and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Aysel AhadovaDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pauline Luise PfudererDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Maarit AhtiainenDepartment of Education and Research, Central Finland Central Hospital, 40620 Jyväskylä, Finland.ORCID 0000-0002-3263-2307
Alexej BallhausenDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.ORCID 0000-0002-5470-4973
Lena BohaumilitzkyDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Svenja KösegiDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Nico MüllerDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Yee Lin TangDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Kosima KosmallaDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Johannes WittDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Volker EndrisDepartment of General Pathology, Institute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0003-2550-3563
Albrecht StenzingerDepartment of General Pathology, Institute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Magnus von Knebel DoeberitzDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Hendrik BläkerInstitute of Pathology, University Hospital Leipzig, 04103 Leipzig, Germany.
Laura Renkonen-SinisaloDepartment of Gastrointestinal Surgery, Helsinki University Hospital, 00290 Helsinki, Finland.
Anna LepistöDepartment of Gastrointestinal Surgery, Helsinki University Hospital, 00290 Helsinki, Finland.
Jan BöhmDepartment of Pathology, Central Finland Central Hospital, 40620 Jyväskylä, Finland.
Jukka-Pekka MecklinDepartment of Education and Research, Central Finland Central Hospital, 40620 Jyväskylä, Finland.
Toni T SeppäläDepartment of Gastrointestinal Surgery, Helsinki University Hospital, 00290 Helsinki, Finland.ORCID 0000-0002-4940-3498
Matthias KloorDepartment of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Cooperation Unit Applied Tumour Biology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
German Cancer Research Center · DECentral Finland Health Care District · FIHeidelberg University · DEHelsinki University Hospital · FIJohns Hopkins University · USUniversity Hospital Leipzig · DE

Funding

Wilhelm Sander-Stiftung 2016.056.1
6 · The paper itself

Abstract

Regular colonoscopy even with short intervals does not prevent all colorectal cancers (CRC) in Lynch syndrome (LS). In the present study, we asked whether cancers detected under regular colonoscopy surveillance (incident cancers) are phenotypically different from cancers detected at first colonoscopy (prevalent cancers). We analyzed clinical, histological, immunological and mutational characteristics, including panel sequencing and high-throughput coding microsatellite (cMS) analysis, in 28 incident and 67 prevalent LS CRCs (

Indexed as

cancer preventioncarcinogenesiscolonoscopy screeningcolorectal cancerincident cancerLynch syndromemicrosatellite instabilitymismatch repair deficiencymutational profiling

Identifiers

PMID34206061
PMCPMC8198627
OpenAlexW3171605222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.